The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.
The hypoxic tumour microenvironment and metastatic progression
Abstract
The microenvironment of solid tumours contains regions of poor oxygenation and high acidity. Growing evidence from clinical and experimental studies points to a fundamental role for hypoxia in metastatic progression. Prolonged hypoxia increases genomic instability, genomic heterogeneity, and may act as a selective pressure for tumour cell variants. Hypoxia can also act in an epigenetic fashion, altering the expression of genes. Hypoxia-induced changes in gene expression alter non-specific stress responses, anaerobic metabolism, angiogenesis, tissue remodeling, and cell-cell contacts. Experimental studies have demonstrated that inhibition of proteins involved in these processes can modify metastasis formation, suggesting a causal role in metastatic progression. Recent advances in high-throughput screening techniques have allowed identification of many hypoxia-induced genes that are involved in the processes associated with metastasis. Here we review the epigenetic control of gene expression by the hypoxic microenvironment and its potential contribution to metastatic progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposing cancer cells to hypoxia ex vivo is known to increase lung colonization after intravenous injection [34].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [34]
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.619 · Cited by 3,276
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,228
Cited by
Sorted by citations
Items 201–300 of 326
Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
Meyers, D. E., Wang, A. A., Thirukkumaran, C. M., & Morris, D. G. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00114 · Cited by 28
Gupta-Saraf, P., & Miller, C. L. (2014) · Oncotarget · doi:10.18632/oncotarget.1767 · Cited by 27
SHEN, W., ZOU, X., CHEN, M., SHEN, Y., HUANG, S., GUO, H., ZHANG, L., & LIU, P. (2013) · Oncology Reports · doi:10.3892/or.2013.2524 · Cited by 26
Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI
Margolis, N. E., Moy, L. P., Sigmund, E. E., Freed, M. E., McKellop, J. A., Melsaether, A. N., & Kim, S. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001254 · Cited by 26
Heparanase expression in gallbladder carcinoma and its correlation to prognosis
Wu, W., Pan, C., Yu, H., Gong, H., & Wang, Y. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04945.x · Cited by 26
Hompland, T., Ellingsen, C., Galappathi, K., & Rofstad, E. K. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.773073 · Cited by 25
Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells
Subarsky, P., & Hill, R. P. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9139-x · Cited by 27
Li, Y., Che, Q., Bian, Y., Zhou, Q., Jiang, F., TONG, H., Ke, J., Wang, K., & Wan, X. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3091 · Cited by 24
Ellingsen, C., Natvig, I., Gaustad, J., Gulliksrud, K., Egeland, T. A. M., & Rofstad, E. K. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0558-8 · Cited by 24
Bioengineering approaches to study multidrug resistance in tumor cells
Fallica, B., Makin, G., & Zaman, M. H. (2011) · Integrative Biology · doi:10.1039/c0ib00142b · Cited by 24
Mittal, K., Choi, D. H., Ogden, A., Donthamsetty, S., Melton, B. D., Gupta, M. V., Pannu, V., Cantuaria, G. H., Varambally, S., Reid, M. D., et al. (2017) · Scientific Reports · doi:10.1038/srep43984 · Cited by 24
A novel 3‐dimensional culture system as an in vitro model for studying oral cancer cell invasion
Duong, H. S., Le, A. D., Zhang, Q., & Messadi, D. V. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00441.x · Cited by 24
Generation and Characterization of Novel Local and Metastatic Human Neuroblastoma Variants
Nevo, I., Sagi‐Assif, O., Edry‐Botzer, L., Amar, D., Maman, S., Kariv, N., Leider–Trejo, L., Savelyeva, L., Schwab, M., Yron, I., et al. (2008) · Neoplasia · doi:10.1593/neo.08402 · Cited by 23
Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives
Xia, Q., Zhang, L., Zhang, J., Sheng, R., Yang, B., He, Q., & Hu, Y. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.007 · Cited by 23
Hypoxia-responsive fluorescent nanoprobe for imaging and cancer therapy
Chen, S., Liu, J., Li, Y., Wu, X., Yuan, Q., Yang, R., & Zheng, J. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116010 · Cited by 23
Gharib, T. G., Chen, G., Huang, C., Misek, D. E., Iannettoni, M. D., Hanash, S., Orringer, M. B., & Beer, D. G. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.n.011 · Cited by 24
Ozone Therapy in Cancer Treatment: State of the Art
Menéndez, S., Cañas, J. C., & Borrego, L. (2008) · Ozone Science and Engineering · doi:10.1080/01919510802473724 · Cited by 22
Tirapazamine Administered as a Neoadjuvant to Radiotherapy Reduces Metastatic Dissemination
Lunt, S. J., Telfer, B. A., Fitzmaurice, R. J., Stratford, I. J., & Williams, K. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2162 · Cited by 22
Kalliomäki, T., McCallum, G. P., Wells, P. G., & Hill, R. P. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.009 · Cited by 20
Radiogenic Therapy: Novel Approaches for Enhancing Tumor Radiosensitivity
Robson, T., Worthington, J., McKeown, S. R., & Hirst, D. G. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400404 · Cited by 21
The Clinical Application of Ozonetherapy
Bocci, V. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9234-2_9 · Cited by 24
Hypoxia alters cathepsin B / inhibitor profiles in oral carcinoma cell lines.
Wickramasinghe, N. S. M. D., Banerjee, K., Nagaraj, N. S., Vigneswaran, N., & Zacharias, W. (2005) · PubMed · Cited by 21
Regulation of ischemic cell death by the lipoic acid–palladium complex, Poly MVA, in gerbils
Antonawich, F. J., Fiore, S. M., & Welicky, L. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.011 · Cited by 21
Kalliomäki, T., McCallum, G. P., Lunt, S. J., Wells, P. G., & Hill, R. P. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-151 · Cited by 20
RETRACTED: Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus Lactis
Garza-Morales, R., Rendon, B. E., Malik, M. T., Garza-Cabrales, J. E., Aucouturier, A., Bermúdez‐Humarán, L. G., McMasters, K. M., McNally, L. R., & Gómez-Gutiérrez, J. G. (2020) · Cancers · doi:10.3390/cancers12020438 · Cited by 20
RetractedThe role of TET-mediated DNA hydroxymethylation in prostate cancer
Smeets, E., Lynch, A. G., Preković, S., den Broeck, T. V., Moris, L., Helsen, C., Joniau, S., Claessens, F., & Massie, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.021 · Cited by 20
Bu, M., Liu, X., Liu, X., & Xu, W. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4827 · Cited by 19
AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
Li, Y., Jia, Y., Che, Q., Zhou, Q., Wang, K., & Wan, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4708 · Cited by 19
Iri�, T., Aida, T., & Tachikawa, T. (2004) · Medical Molecular Morphology · doi:10.1007/s00795-003-0242-z · Cited by 19
Microenvironment-associated lymph node metastasis of human cervical carcinoma xenografts
Ellingsen, C., Hompland, T., Mathiesen, B. S., & Rofstad, E. K. (2012) · Acta Oncologica · doi:10.3109/0284186x.2011.636751 · Cited by 18
A microfluidic chip of multiple-channel array with various oxygen tensions for drug screening
Li, Y., Li, L., Liu, Z., Ding, M., Luo, G., & Liang, Q. (2016) · Microfluidics and Nanofluidics · doi:10.1007/s10404-016-1762-x · Cited by 18
Medical ozone and radiotherapy in a peritoneal, Erlich-ascites, tumor-cell model.
Kızıltan, H. Ş., Bayır, A. G., Yucesan, G., Eriş, A. H., İdin, K., Karatoprak, C., Aydın, T., Akçakaya, A., & Mayadağlı, A. (2015) · PubMed · Cited by 18
Bhargav, H., Metri, K., Nagarathna, R., Ramarao, N. H., & Koka, P. S. (2012) · PubMed · Cited by 17
A multiple time-scale computational model of a tumor and its micro environment
DuBois, C., Farnham, J., Aaron, E., & Radunskaya, A. (2012) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2013.10.121 · Cited by 17
Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis
Cheung, A. H. K., Iyer, D. N., Lam, C., Ng, L., Wong, S. H., Lee, H.-S., Wan, T. M.-H., Man, J. H.-W., Chow, A. K.-M., Poon, R. T. P., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061106 · Cited by 17
Rezapour, M., Wesolowski, R., & Gürcan, M. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137306 · Cited by 18
Chen, Z., Xue, Y., Zhang, Z., Li, W., Wen, M., Zhao, Y., Li, J., Weng, Z., & Ye, Q. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.108865 · Cited by 16
Hypoxia-regulated p53 and its effect on radiosensitivity in cancer cells
Zhang, L., Subarsky, P., & Hill, R. P. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701373708 · Cited by 16
Mitophagy in tumor: foe or friend?
Li, L., & Hu, F. (2023) · Endokrynologia Polska · doi:10.5603/ep.95652 · Cited by 15
Park, S., Kim, Y. S., Lee, H. A., Lim, Y., & Kim, Y. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120763 · Cited by 15
Graat, H. C. A., Wuisman, P. I. J. M., van Beusechem, V. W., Carette, J. E., Gerritsen, W. R., Bras, J., Schaap, G. R., & Kaspers, G. J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2375 · Cited by 15
Synthesis and evaluation of a novel 99mTc-labeled bioreductive probe for tumor hypoxia imaging
Kimura, S., Umeda, I. O., Moriyama, N., & Fujii, H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.022 · Cited by 14
Khakshour, S., Labrecque, M. P., Esmaeilsabzali, H., Lee, F. J. S., Cox, M., Park, E. J., & Beischlag, T. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-07947-6 · Cited by 14
Nivet, A., Schlienger, M., Clavère, P., & Huguet, F. (2019) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2018.05.009 · Cited by 13
Skowronki, K., Andrews, J., Rodenhiser, D. I., & Coomber, B. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103243 · Cited by 12
Zhang, Q., Huang, H., & Chu, T. (2015) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3365 · Cited by 12
Attenuation of Colon Carcinoma Tumor Spread by Intravenous Immunoglobulin
Damianovich, M., Solomon, A., Blank, M., & Shoenfeld, Y. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.061 · Cited by 12
The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia
Hirai, K., Nomura, T., Yamasaki, M., Inoue, T., Narimatsu, T., Nakada, C., Tsukamoto, Y., Matsuura, K., Sato, F., Moriyama, M., et al. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.09.005 · Cited by 12
Hypoxic tumor therapy based on free radicals
Zheng, J., Pan, Y., Chen, Y., Li, J., & Li, W. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00206c · Cited by 11
Molecular Theranostic Agent with Programmed Activation for Hypoxic Tumors
Koo, S., Bobba, K. N., Cho, M. Y., Park, H. S., Won, M., Velusamy, N., Hong, K. S., Bhuniya, S., & Kim, J. S. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00722 · Cited by 11
Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer
Qu, X., Zhang, Y., Sang, X., Ren, D., Zhao, H., & Wong, S. T. C. (2022) · Cancers · doi:10.3390/cancers14133195 · Cited by 11
Måseide, K., Pintilie, M., Kandel, R. A., & Hill, R. P. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2007.10.009 · Cited by 11
Gene therapy approaches to enhance bioreductive drug treatment
Cowen, R. L., Garside, E., Fitzpatrick, B., Papadopoulou, M. V., & Williams, K. J. (2008) · British Journal of Radiology · doi:10.1259/bjr/55070206 · Cited by 11
Belkacemi, L., Lam, E. K. K., Caldwell, J. D., Siemens, D. R., & Graham, C. H. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.02.004 · Cited by 10
Markers of Circulating Breast Cancer Cells
López-Muñoz, E., & Méndez-Montes, M. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-407680-8.00007-5 · Cited by 10
Li, Q., Lin, Q., Kim, H., & Yun, Z. (2017) · Europe PMC (PubMed Central) · Cited by 10
Zhu, J., Hao, S., Zhang, X., Qiu, J., Xuan, Q., & Ye, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.637320 · Cited by 10
Zhang, H., Chen, X., Li, S., Shen, J., & Mao, Z. (2022) · Molecules · doi:10.3390/molecules27092629 · Cited by 10
XBP1 is essential for survival under hypoxic conditions and is required for tumor growth
Romero, L., Cao, H., Hammond, E. M., Giaccia, A. J., Le, Q., & Koong, A. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.06.130 · Cited by 10
The Lymph Node Microenvironment May Invigorate Cancer Cells With Enhanced Metastatic Capacities
Li, T., Liu, T., Zhao, Z., Xu, X., Zhan, S., Zhou, S., Jiang, N., Zhu, W., Sun, R., Wei, F., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.816506 · Cited by 12
Chapter 8 Noninvasive Imaging of Blood Vessels
Makale, M. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)02808-5 · Cited by 10
Banáth, J. P., Sinnott, L., Larrivée, B., MacPhail, S. H., & Olive, P. L. (2005) · Radiation Research · doi:10.1667/3474.1 · Cited by 10
Johansson, A., Rudolfsson, S. H., Kilter, S., & Bergh, A. R. J. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09690.x · Cited by 10
Mei, L., Sun, W., & Chu, T. (2014) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-014-3235-6 · Cited by 9
Targeted treatment: insights from studies of osteopontin and hypoxia
Hill, R. P. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70363-6 · Cited by 9
Smart Nanogatekeepers for Tumor Theranostics
Zhang, X., Chen, Y., He, X., Zhang, Y., Zhou, M., Peng, C., He, Z., Gui, S., & Li, Z. (2021) · Small · doi:10.1002/smll.202103712 · Cited by 8
Hypoxia-activated cytotoxicity of benznidazole against clonogenic tumor cells
Li, Q., Lin, Q., & Yun, Z. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1250988 · Cited by 8
Proliferation and Death in a Binary Environment: A Stochastic Model of Cellular Ecosystems
Chignola, R., Pra, P. D., Morato, L. M., & Siri, P. (2006) · Bulletin of Mathematical Biology · doi:10.1007/s11538-006-9078-8 · Cited by 8
Vijayakumar, S., Henegan, J. C., Zhang, X., Wang, W., Day, W. A., Vijayakumar, V., Moreno, C. S., & Gómez, C. R. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.04.003 · Cited by 7
Hypoxia, Tumor Endothelium, and Targets for Therapy
Teicher, B. A. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-26206-7_5 · Cited by 7
Microenvironmental Effects on Tumour Progression and Metastasis
Måseide, K., Kalliomäki, T., & Hill, R. P. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_1 · Cited by 7
Beri, K. (2017) · International Journal of Yoga · doi:10.4103/0973-6131.205512 · Cited by 6
Autoencoder Networks Decipher the Association between Lung Cancer and Alzheimer’s Disease
Li, J., Gao, X., Tang, M., Wang, C., Liu, W., & Tian, S. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/2009545 · Cited by 6
Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma
Liu, J., Zhao, J., & Qiao, X. (2023) · Endocrinology · doi:10.1210/endocr/bqad139 · Cited by 6
Baumann, M. A., Bodis, S. B., Dikomey, E., van der Kogel, A., Overgaard, J., Rodemann, H. P., & Wouters, B. G. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.10.001 · Cited by 6
Zhang, Q., Zhang, Q., Guan, Y.-X., Liu, S., Chen, Q., & Li, X. (2016) · Medical Science Monitor · doi:10.12659/msm.898659 · Cited by 6
Redox activated polymeric nanoparticles in tumor therapy
Alimoradi, H., Matikonda, S. S., Gamble, A. B., Giles, G. I., & Griesh, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00010-5 · Cited by 6
Zeng, G., Wang, T., Zhang, J., Kang, Y. J., & Feng, L. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13220 · Cited by 5
Expression of Laminin β2: A Novel Marker of Hypoxia in Pituitary Adenomas
Bao, Y., Yoshida, D., Morimoto, D., & Teramoto, A. (2006) · Endocrine Pathology · doi:10.1385/ep:17:3:251 · Cited by 5
Targeting Cancer Stem Cells—A Renewed Therapeutic Paradigm
Amey, C. L., & Karnoub, A. E. (2017) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2017.13.01.45 · Cited by 4
Lu, X., Wang, X., Gao, S., Chen, Z., Bai, R., & Wang, Y. (2023) · The Analyst · doi:10.1039/d3an00972f · Cited by 4
Rajaganeshan, R., Jayne, D. G., Malik, H. M. A., Scott, N., Lodge, J. P. A., Toogood, G. J., & Prasad, R. K. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.03.017 · Cited by 4
Organic nanocarriers for targeted delivery of anticancer agents
Dahiya, S., & Dahiya, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00010-9 · Cited by 4
Human activated macrophages and hypoxia: a comprehensive review of the literature.
Sotoodehnejadnematalahi, F., & Burke, B. (2014) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2014.3708 · Cited by 5
Brown, J. M., & Graves, E. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-53632-7.00806-6 · Cited by 4
Natural Products as Probes of Selected Targets in Tumor Cell Biology and Hypoxic Signaling
Nagle, D. G., & Zhou, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00054-x · Cited by 4
Silk scaffolds for three-dimensional (3D) tumor modeling
Talukdar, S., & Kundu, S. C. (2014) · Elsevier eBooks · doi:10.1533/9780857097064.3.472 · Cited by 4
Mathematical reconstruction of the metabolic network in an in-vitro multiple myeloma model
Vera-Sigüenza, E., Escribano-Gonzalez, C., Serrano‐Gonzalo, I., Eskla, K., Spill, F., & Tennant, D. A. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011374 · Cited by 3
Morrison, G., Henry, N., Kopytynski, M., & Chen, R. (2024) · Biomaterials Science · doi:10.1039/d4bm00600c · Cited by 3
Self-Assembled Polymeric Nanomicelles as Delivery Carriers for Antitumor Drug Camptothecin
Zeng, J., Yu, J., Huang, J., & Chang, P. R. (2012) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2011.562407 · Cited by 3
Expression of Carbonic Anhydrase IX Correlates with Histologic Grade and Metastasis in Osteosarcoma
Park, H., Seo, J., Bacchini, P., Bertoni, F., & Park, Y.-K. (2010) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2010.44.4.384 · Cited by 3
Ozaki, T., Nakamura, M., Ogata, T., Sang, M., & Shimozato, O. (2017) · Current human cell research and applications · doi:10.1007/978-981-10-7296-3_5 · Cited by 3
Angiogenesis and vascular survival ability in ovarian adenocarcinomas
Giatromanolaki, A. N., Sivridis, E., Tsikouras, P., Manavis, I., Maroulis, G., & Koukourakis, M. I. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1089-y · Cited by 3
Mitophagy in lymph node metastasis: Mechanisms, immune consequences and therapeutic opportunities
Ju, J., Zhu, W., & Zhang, Y. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105386 · Cited by 3
Synthesis and evaluation of new dinitrobenzamide mustards in human prostate cancer
Basiri, A., Zhang, W., & Garrison, J. C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127697 · Cited by 2
Pandey, N., Chongtham, J., Pal, S., Ali, A., Lalwani, S., Jain, D., Mohan, A., & Srivastava, T. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119302 · Cited by 2
Biological Microniches Characterizing Pathological Lesions
Meraz, I. M., Segura-Ibarra, V., Leonard, F., Gonzalez, J., Ally, S., Godin, B., & Serda, R. E. (2013) · Frontiers of nanoscience · doi:10.1016/b978-0-08-098338-7.00006-6 · Cited by 2
Combination effects of sorafenib with PI3K inhibitors under hypoxia in colorectal cancer
Bhatia, D. R., & Thiagarajan, P. (2016) · Hypoxia · doi:10.2147/hp.s115500 · Cited by 2
Application of Functional Molecular Imaging in Radiation Oncology
Naz, S., Krishna, M. C., & Mitchell, J. B. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-40854-5_5 · Cited by 1
Kızıltan, H. Ş. (2017) · MOJ Clinical & Medical Case Reports · doi:10.15406/mojcr.2017.06.00165 · Cited by 1
Metadata
- Authors
- Subarsky, P., & Hill, R. P.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Hill, Richard P.
- ORCID
- Hill, Richard P.
- Venue
- Clinical & Experimental Metastasis
- Published
- 2003-05
- Volume
- 20
- Issue
- 3
- Pages
- 237-250
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W122518273
- Cited by
- 327
- References
- 132
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 7 · 2022: 8 · 2021: 12 · 2020: 10 · 2019: 9 · 2018: 4 · 2017: 23 · 2016: 17 · 2015: 12 · 2014: 14 · 2013: 17 · 2012: 9
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- tumor hypoxia, tumor microenvironment, metastatic progression, genomic instability, genomic heterogeneity, epigenetic regulation, hypoxia-induced gene expression, anaerobic metabolism, angiogenesis, tissue remodeling, cell-cell contact, high-throughput screening, anti-metastatic agents
- MeSH terms
- Animals, Humans, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review